Open Access

It is time to reconsider aspirin as a routine therapy for secondary prevention after STEMI - PRO.(Via ZOOM)

Congress Presentation

About the speaker

Professor Pascal Vranckx

Heart Centre Hasselt, Hasselt (Belgium)
31 presentations
4 followers

9 more presentations in this session

Risk scores are helpful for defining optimal DAPT duration - PRO.

Speaker: Professor S. De Servi (Sesto San Giovanni, IT)

Thumbnail

Risk scores are helpful for defining optimal DAPT duration - CONTRA.

Speaker: Professor A. Budaj (Warsaw, PL)

Thumbnail

Risk scores are helpful for defining optimal DAPT duration - Rebuttal PRO.

Speaker: Professor S. De Servi (Sesto San Giovanni, IT)

Thumbnail

Risk scores are helpful for defining optimal DAPT duration - Rebuttal CONTRA.

Speaker: Professor A. Budaj (Warsaw, PL)

Thumbnail

Risk scores are helpful for defining optimal DAPT duration: Chairpersons conclusion.

Thumbnail

Access the full session

Great debate on STEMI: current controversies on antiplatelet management after the acute phase

Speakers: Professor P. Vranckx, Professor S. De Servi, Professor A. Budaj, Professor S. De Servi, Professor A. Budaj
Thumbnail

About the event

Image

Acute Cardiovascular Care 2018

3 March - 5 March 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb